Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High vs Low Dose Caffeine for Apnea of Prematurity
NCT02103777Phase 3Completed
- Sponsor
- Mansoura University Children Hospital
- Start
- Sep 2011
- Primary completion
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of caffeine in apnea of prematurity (AOP) (2 arms), sponsored by Mansoura University Children Hospital. Primary endpoint: Successful extubation from mechanical ventilation. Started Sep 2011; status: completed.
02
Drugs
caffeine
03
Conditions
apnea of prematurity (AOP)
Beyond the preview
Go deeper on NCT02103777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02103777.